about
Anti-CD38 autoantibodies in type? diabetesPotential roles of GPR120 and its agonists in the management of diabetesMolecular mechanistic associations of human diseasesGlucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).Maternal vitamin D status in type 1 diabetic pregnancy: impact on neonatal vitamin D status and association with maternal glycaemic control.Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study.Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes.Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency.Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHCSystematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approachPre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.Adiponectin-SOGA Dissociation in Type 1 Diabetes.Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus.The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.Major increase in Type 1 diabetes: no support for the Accelerator Hypothesis.The clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years.Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis.The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysisImprovement in insulin sensitivity after human islet transplantation for type 1 diabetes.The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.Diabetic Retinopathy and Diabetic Macular Edema.Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus.[Cardiovascular disease in type 1 diabetes mellitus].Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes.Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.A pharmacokinetic model of a tissue implantable insulin sensor.
P2860
Q24652207-D2BDA6B2-D17E-4CD5-AAA9-1B066F9F67EEQ26827101-09A3F74A-8A67-44D0-8C2F-906E2E4CF450Q30496754-1548D157-E976-4DEE-BFCA-4C58E0D137F8Q30505367-3590C2C1-314F-4778-AACC-0FC9592374FFQ31137784-AC64CE28-66CD-4323-A003-66188A35096AQ33626279-98E09EEA-1EDE-4851-944D-0D1BEFFB0307Q33628076-910BADBE-180A-44E9-BA5B-F543ABB36E24Q33759055-099C2059-C076-448E-9156-0FE9B6F0E395Q34072322-7EDA66C2-FA25-4F85-B89C-BFBEB892A4FEQ34351648-D269143E-7AA6-4FC2-8B3A-E03DB67ED3C9Q34363187-5B485E84-5B40-4F81-A127-8117E2E6EFDCQ34486702-47ECCAC6-6AC6-4522-92B6-7DA193BA4022Q35122357-9FD92AAF-EB3B-42C5-BFF6-B9A18A162FA6Q35612681-8249167F-53D5-4132-A581-6A898F1DBB6CQ35749422-59CD4FB9-1B56-4CEF-ADF8-B236E0161D05Q35792511-CE5B9887-9490-4AD4-B97C-91945E244A1AQ35916487-627A15AD-61F2-4DE3-A8AB-DC292652E6F6Q35921374-0246F3AF-F006-431A-B5F1-B0D0473BBD35Q35958600-7D6D9F67-7F32-4F3B-854F-55F15F81CA5EQ35976782-3B5763B5-9F29-47B1-96BE-728A42DFE891Q36249543-780DC18A-A082-4EBB-80DC-1189840B0156Q36792589-4329656D-31A7-4E6B-8BAF-4CEF7E6A428CQ36834380-5B9EA6F6-D34D-4ABF-9291-21384BA8F0AEQ37147347-1871D0C6-2757-4525-98CA-27DD5E962211Q37186774-BEE0E235-F8B9-4754-88A5-EB1A34661A1BQ37257559-2513E0B5-4FA6-43BE-A1C8-BB66D0F5AFA5Q37276007-8CF09C07-5DCE-44A0-88D5-7E9829A2064FQ37511687-171DDA15-DAF1-40D1-BBF4-B50227C1A0C3Q37590634-40FE81DB-1FCA-4ABE-B29E-D03102656950Q37832964-AA9BCBEB-B35B-45AD-8839-7D1D6ADEF45CQ38580783-DD5A3094-B8CB-46A4-8A64-0958AF069551Q38616344-E0CD1E02-8FB9-42EA-8DF3-3ED2E144CE53Q39175261-58E23ECE-ADAE-4D3A-9A75-1F3954CF7406Q42204883-6C9DA409-13D8-408A-9D0C-01950E86A09FQ46625403-88BC83F5-5A11-4EB0-96BB-E22E450BB5C3Q46923315-EA0C28C1-16C9-46DD-A5B8-51BCD705FEB5Q47365110-5055EFCD-C62B-49F8-8EF3-83AFD663442DQ47885313-54B77D4E-93D0-462E-8F1B-A7F9550942A8Q50630504-42D8775D-70AD-4DB3-B6D4-C5AB1733AE63Q51062870-EF68897F-5F77-42F0-9095-08804780867E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin resistance in type 1 diabetes.
@ast
Insulin resistance in type 1 diabetes.
@en
Insulin resistance in type 1 diabetes.
@nl
type
label
Insulin resistance in type 1 diabetes.
@ast
Insulin resistance in type 1 diabetes.
@en
Insulin resistance in type 1 diabetes.
@nl
prefLabel
Insulin resistance in type 1 diabetes.
@ast
Insulin resistance in type 1 diabetes.
@en
Insulin resistance in type 1 diabetes.
@nl
P2860
P356
P1476
Insulin resistance in type 1 diabetes.
@en
P2093
Carla J Greenbaum
P2860
P304
P356
10.1002/DMRR.291
P577
2002-05-01T00:00:00Z